About Christopher Weidenmaier
Christopher Weidenmaier studied biology and earned a Ph.D. in microbiology from the University of Tübingen, Germany. He held postdoctoral positions in the laboratories of Andreas Peschel at the University of Tübingen, and Jean Lee at the Division of Infectious Diseases of the Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Since 2009, he has worked as an independent principal investigator at the Interfaculty Institute for Microbiology and Infection Medicine, University of Tübingen. His research is focused on the role of cell wall polymers of Staphylococcus aureus in staphylococcal pathogenesis.
Recent studies that demonstrate a striking impact of microbiome composition on the efficacy of certain cancer therapies shed a new light on the the role of the microbiome in cancer development and treatment .